Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108

NCT07153172 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
91
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S